Abstracts

Evaluation of HIV-1 Latency-Reversing Agents by a Modified Virus Growth Assay (VOA)

Background: Inhibitors of histone deacetylases (HDACis) reactivate HIV replication in in vitro models of HIV latency. However, the recent study by Bullen et al. has underscored the difficulty to reactivate HIV-1 latency in primary resting memory CD4 T cells isolated from aviremic long-term treated HIV-1 infected patients (Bullen et al., Nature Medicine 2014). We hypothesized…

Impact of Combination of Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation for Lymphoma on HIV Reservoir Persistence

Background: Myeloablation and autologous stem cell transplantation (ASCT) lead to significant depletion of circulating CD4+ T cells and could impact the HIV-1 reservoir. We studied the longitudinal effect of combination chemotherapy and ASCT for HIV-related lymphoma on cellular HIV-1 DNA quantification in patients on suppressive antiretroviral therapy. Methods: Between 2012 and 2014, we analyzed antiretroviral…

HIV-1 Reservoirs and Humoral Immunity in Allogeneic Stem Cell Transplantation Patients

Background: Previous studies have shown that HIV-1 reservoirs are reduced following allogeneic hematopoietic stem cell transplantation (HSCT), but that HIV-specific antibodies (Abs) remain detectable over time. It is unknown whether these Abs reflect new responses to occult antigen or the persistence of recipient-derived Abs. Therefore, we characterized HIV-1 reservoirs and evolution of humoral immunity in…